Disorganisation of cytoskeleton in cells resistant to photodynamic treatment with decreased metastatic phenotype.
The appearance of cells resistant to photodynamic therapy (PDT) is crucial for the outcome of this antitumoral treatment. We had previously isolated two sublines resistant to PDT derived from the mammary adenocarcinoma LM3 [A. Casas, C. Perotti, B. Ortel, G. Di Venosa, M. Saccoliti, A. Batlle, T. Hasan, Induction of murine tumour cell lines resistant to ALA-mediated Photodynamic Therapy, Int. J. Oncol. 29 (2006) 397-405.]. These clones have severely impaired its metastatic potential in vivo together with decreased general anchorage-dependent adhesion and invasion. In the present work we analyzed the differential expression and distribution of cytoskeleton and adhesion proteins in these cell lines. In both resistant clones, loss of actin stress fibers and disorganization of the actin cortical rim was observed. E-cadherin and beta-catenin and vinculin distribution was also disorganized. However, Western blot assays did not show differential expression of actin, E-cadherin, vinculin or beta-catenin. It was demonstrated that PDT strongly affects cell-cell and cell-substrate adhesion through the reorganization of some cytoskeletal and adhesion proteins. Changes in the metastasis phenotypes previously found are likely to be ascribed to these differences.
Casas
Adriana
A
Centro de Investigaciones sobre Porfirinas y Porfirias, CONICET and Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Córdoba 2351, 1er subsuelo, Ciudad de Buenos Aires, Argentina. adriana@qb.fcen.uba.ar
Sanz-Rodriguez
Francisco
F
Di Venosa
Gabriela
G
Rodriguez
Lorena
L
Mamone
Leandro
L
Blázquez
Alfonso
A
Jaén
Pedro
P
Batlle
Alcira
A
Stockert
Juan C
JC
Juarranz
Angeles
A
D000199:Actins / Q000032:analysis; D000622:Aminolevulinic Acid / Q000627:therapeutic use*; D000818:Animals; D015820:Cadherins / Q000032:analysis; D002448:Cell Adhesion / Q000187:drug effects; D003599:Cytoskeleton / Q000187:drug effects*; D019008:Drug Resistance, Neoplasm; D051416:Focal Adhesion Protein-Tyrosine Kinases / Q000032:analysis; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy* / Q000473:pathology; D051379:Mice; D009362:Neoplasm Metastasis; D010641:Phenotype; D010778:Photochemotherapy; D016596:Vinculin / Q000032:analysis; D051176:beta Catenin / Q000032:analysis
D000199:Actins; D015820:Cadherins; D051176:beta Catenin; D016596:Vinculin; D000622:Aminolevulinic Acid; D051416:Focal Adhesion Protein-Tyrosine Kinases